The benzyl alcohol inhibits the growth of bacteria, allowing the vial to be used multiple times after it has been punctured
doi:10.1016/S0140-6736(21)01751-7 DAscanio AM, Mullally JA, Frishman WH
Gastrointestinal Therapeutics Given BPC-157's origin from gastric juice and extensive preclinical evidence for gastrointestinal protection, digestive system applications warrant clinical investigation
It appears to shorten the inflammation phase
Research indicates particular efficacy for attention-related tasks, with subjects showing enhanced focus duration and reduced distractibility
Its design pairs two structurally unrelated peptides, TB-500, a synthetic thymosin beta-4 active fragment, and BPC-157, a gastric-origin pentadecapeptide, that operate through fundamentally different cellular mechanisms but converge on tissue-repair and remodeling outcomes